US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Latest News about Kidney Cancer

Recent news which mentions Kidney Cancer

Aravive Highlights Updated Batiraxcept Data From Kidney Cancer Trial
Tickers ARAV
Tags Penny Stocks General Kidney Cancer
From Benzinga
Alkermes' Nemvaleukin Shows Encouraging Anti-Tumor Activity In Pretreated Kidney Cancer
Tickers ALKS
Tags Phase 1 Trial Phase 2 Trial Trading Ideas
From Benzinga
Merck's Keytruda Scores First Approval In Adjuvant Kidney Cancer Setting
Tickers MRK
Tags FDA Health Care News
From Benzinga
See Why Sonnet BioTherapeutics Stock Is Skyrocketing In Premarket Tuesday
Tickers SONN
Tags Biotech Movers Benzinga
From Benzinga